Harpreet Nijjer | Biomarker Research | Innovative Research Award

Innovative Research Award

Harpreet Nijjer
Stanford University, United States
Harpreet Nijjer
Affiliation Stanford University
Country United States
Scopus ID 60497688600
Documents 1
Subject Area Biomarker Research
Event Global Composite Awards

Harpreet Nijjer is a researcher affiliated with Stanford University in the United States whose documented research profile includes work categorized under Biomarker Research. The research profile identified for this academic recognition contains one Scopus-indexed document and is associated with Scopus Author ID 60497688600. Biomarker research encompasses the identification, characterization, validation, and application of measurable biological indicators that can support the understanding of physiological processes, disease mechanisms, diagnosis, prognosis, and treatment response. [1]

Abstract

The Innovative Research Award recognition presented in this profile highlights research associated with the field of Biomarker Research. Harpreet Nijjer, affiliated with Stanford University, is identified in the supplied academic record by Scopus Author ID 60497688600 and one documented Scopus publication. Biomarker research is an interdisciplinary area connecting molecular biology, medicine, diagnostics, data analysis, and translational science. Its objectives can include identifying measurable biological characteristics that provide information about normal biological processes, pathological conditions, or responses to interventions. The development of reliable biomarkers generally involves stages of discovery, analytical characterization, validation, and assessment of clinical or research utility.[1]

Keywords

Biomarker Research, Biomarker Discovery, Biomarker Validation, Molecular Biomarkers, Clinical Biomarkers, Diagnostic Research, Translational Research, Precision Medicine, Molecular Diagnostics, Biomedical Innovation, Disease Detection, Research Excellence, Innovative Research Award.

Introduction

Biomarkers are measurable characteristics that can provide information about biological processes, pathogenic processes, or responses to an exposure or intervention. The biomarker field therefore extends across molecular, cellular, physiological, imaging, and other measurable domains. Contemporary biomarker research places emphasis not only on identifying candidate indicators but also on demonstrating their analytical validity, biological relevance, reproducibility, and usefulness for a defined application.[1]

Research Profile

Harpreet Nijjer is identified in the supplied profile as being affiliated with Stanford University, United States. The academic subject classification associated with the recognition is Biomarker Research. The profile lists Scopus Author ID 60497688600 and one Scopus document. These identifiers and publication counts provide a bibliographic snapshot of the supplied record rather than a comprehensive assessment of the researcher’s complete scholarly activity. [3]

Research Contributions

Research within Biomarker Research can contribute to several interconnected stages of biomedical investigation. These stages commonly include the identification of candidate biomarkers, biological characterization, analytical measurement, validation in relevant populations or experimental settings, and evaluation of their usefulness for a specified purpose.[1]

Publications

The supplied Scopus profile records 1 document for Harpreet Nijjer under Scopus Author ID 60497688600. Because a specific publication title, journal, publication year, and DOI were not provided in the source information supplied for this page, no publication details are inferred here. The Scopus author profile can be consulted for the bibliographic record and any available publication metadata. [3]

Research Impact

The potential impact of biomarker research extends from fundamental biological investigation to clinical and translational applications. Validated biomarkers can support disease characterization, risk assessment, monitoring, and the investigation of responses to therapeutic interventions. Their usefulness depends on evidence demonstrating that the measurement is sufficiently reliable and that it provides meaningful information for the defined research or clinical purpose.[2]

Award Suitability

The Innovative Research Award is associated with research demonstrating an identifiable focus on innovation and scholarly contribution within its stated subject area. Based on the supplied information, Harpreet Nijjer’s profile is associated with Biomarker Research and Stanford University, with one Scopus-indexed document identified under Scopus Author ID 60497688600. These documented attributes provide the academic context for consideration under an innovation-focused research recognition. [3]

Conclusion

Harpreet Nijjer’s academic profile, as supplied for this recognition page, is associated with Stanford University and the research domain of Biomarker Research. The record identifies Scopus Author ID 60497688600 and one Scopus document. Biomarker research represents an interdisciplinary field in which discovery, characterization, validation, and application of biological indicators are central themes. The Innovative Research Award recognition provides an academic context for highlighting research activity within this area while maintaining a distinction between documented bibliographic information and broader assessments of research impact. [1] [3]

References

  1. Influence of Early Life Adversity on Academic, Behavioral, and Health Outcomes at Elementary School
    https://doi.org/10.1016/j.acap.2026.103260
  2. FDA-NIH Biomarker Working Group. (n.d.). Biomarkers, EndpointS, and other Tools (BEST) Resource. National Center for Biotechnology Information.
    https://www.ncbi.nlm.nih.gov/books/NBK338448/
  3. Elsevier. (n.d.). Scopus author details: Harpreet Nijjer, Author ID 60497688600. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=60497688600